A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia

NCT07223021 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

130

Enrollment

OTHER

Sponsor class

Conditions

B-cell Acute Lymphoblastic Leukemia

Interventions

DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: CAR-T

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]